Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

cellohealthinsight

- PMLiVE

Regeneron’s COVID-19 antibody cocktail enters phase 3 trial

Drug will be evaluated in preventative trial testing uninfected participants

- PMLiVE

Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK

Alleged deal could include agreement for 60 million doses

- PMLiVE

Launch leaders’ blog part 1

To delay or not to delay the launch – ‘that is the question’ nowadays

- PMLiVE

WHO takes stock of global COVID-19 R&D progress

Researchers and developers meet virtually to discuss progress

- PMLiVE

Syneos Health appoints trio of senior hires

Ian Dorrian, JD Cassidy and Maria Tender bolster senior leadership team

- PMLiVE

Syneos Health appoints Tim Pantello as president of communications

Brings nearly 25 years of experience across strategy, marketing and technology

- PMLiVE

The best work in healthcare communications shines at virtual Communiqué Awards

First virtual awards takes social media by storm

- PMLiVE

NHS test and trace system ‘still not good enough’ says health leader

Test and trace system falls short in latest figures

- PMLiVE

Mearns & Pike, Electric Putty and Evoke KYNE make a clean sweep at Communiqué 2020

Respective projects for Crohn’s and Colitis UK win across the board

- PMLiVE

Q&A: Kate Callan

What gets you out of bed in the morning?My four-year-old is notorious for climbing into bed for morning snuggles as soon as the sun rises. If I managed to sleep...

- PMLiVE

Step forward for health charities

The repercussions of COVID-19 will continue to have an impact long after some form of normality returns

- PMLiVE

The search for treatments for Parkinson’s disease

The research requires resilience but pharma is urged to ‘keep innovating, keep trying’

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links